These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23095091)

  • 61. Biliopancreatic diversion induces villi elongation and cholecystokinin and ghrelin increase.
    Mendieta-Zerón H; Larrad-Jiménez Á; Burrell MA; Rodríguez MM; Da Boit K; Frühbeck G; Diéguez C
    Diabetes Metab Syndr; 2011; 5(2):66-70. PubMed ID: 22813405
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
    Carmody JS; Muñoz R; Yin H; Kaplan LM
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass.
    Fenske WK; Bueter M; Miras AD; Ghatei MA; Bloom SR; le Roux CW
    Int J Obes (Lond); 2012 Mar; 36(3):379-84. PubMed ID: 21694700
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Guanylin and uroguanylin mRNA expression is increased following Roux-en-Y gastric bypass, but guanylins do not play a significant role in body weight regulation and glycemic control.
    Fernandez-Cachon ML; Pedersen SL; Rigbolt KT; Zhang C; Fabricius K; Hansen HH; Elster L; Fink LN; Schäfer M; Rhee NA; Langholz E; Wandall E; Friis SU; Vilmann P; Kristiansen VB; Schmidt C; Schreiter K; Breitschopf K; Hübschle T; Jorsal T; Vilsbøll T; Schmidt T; Theis S; Knop FK; Larsen PJ; Jelsing J
    Peptides; 2018 Mar; 101():32-43. PubMed ID: 29289697
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enteroendocrine secretion after Roux-en-Y gastric bypass: is it important?
    Vella A
    Neurogastroenterol Motil; 2013 Jan; 25(1):1-3. PubMed ID: 23279727
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Suboptimal Weight Loss 13 Years After Roux-en-Y Gastric Bypass Is Associated with Blunted Appetite Response.
    Nymo S; Lundanes J; Eriksen K; Aukan M; Rehfeld JF; Holst JJ; Johnsen G; Græslie H; Kulseng B; Sandvik J; Martins C
    Obes Surg; 2024 Feb; 34(2):592-601. PubMed ID: 38159146
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of distal-ileal exclusion after Roux-en-Y gastric bypass on glucose tolerance and GLP-1 response in type-2 diabetes Sprague-Dawley rat model.
    Dolo PR; Li C; Zhu X; Yao L; Meng S; Hong J
    Surg Obes Relat Dis; 2018 Oct; 14(10):1552-1560. PubMed ID: 30122358
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intermittent Hypoxia Up-Regulates Gene Expressions of
    Shobatake R; Itaya-Hironaka A; Yamauchi A; Makino M; Sakuramoto-Tsuchida S; Uchiyama T; Ota H; Takahashi N; Ueno S; Sugie K; Takasawa S
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991633
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Roux-en-Y Gastric Bypass Improves Hepatic Glucose Metabolism Involving Down-Regulation of Protein Tyrosine Phosphatase 1B in Obese Rats.
    Mu S; Liu J; Guo W; Zhang S; Xiao X; Wang Z; Zhang J
    Obes Facts; 2017; 10(3):191-206. PubMed ID: 28564652
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Takeda G Protein-Coupled Receptor 5-Mechanistic Target of Rapamycin Complex 1 Signaling Contributes to the Increment of Glucagon-Like Peptide-1 Production after Roux-en-Y Gastric Bypass.
    Zhai H; Li Z; Peng M; Huang Z; Qin T; Chen L; Li H; Zhang H; Zhang W; Xu G
    EBioMedicine; 2018 Jun; 32():201-214. PubMed ID: 29859856
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity.
    Näslund E; Grybäck P; Hellström PM; Jacobsson H; Holst JJ; Theodorsson E; Backman L
    Int J Obes Relat Metab Disord; 1997 May; 21(5):387-92. PubMed ID: 9152741
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus).
    Blanco AM; Bertucci JI; Valenciano AI; Delgado MJ; Unniappan S
    Horm Behav; 2017 Jul; 93():62-71. PubMed ID: 28506816
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
    Liu Y; Zhou Y; Wang Y; Geng D; Liu J
    Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of Roux-en-Y gastric bypass and ileal transposition surgeries on glucose and lipid metabolism in skeletal muscle and liver.
    Pezeshki A; Chelikani PK
    Surg Obes Relat Dis; 2014; 10(2):217-28. PubMed ID: 24603111
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study.
    Miras AD; Kamocka A; Pérez-Pevida B; Purkayastha S; Moorthy K; Patel A; Chahal H; Frost G; Bassett P; Castagnetto-Gissey L; Coppin L; Jackson N; Umpleby AM; Bloom SR; Tan T; Ahmed AR; Rubino F
    Diabetes Care; 2021 May; 44(5):1082-1090. PubMed ID: 33158945
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
    le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
    Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.
    Korner J; Inabnet W; Febres G; Conwell IM; McMahon DJ; Salas R; Taveras C; Schrope B; Bessler M
    Int J Obes (Lond); 2009 Jul; 33(7):786-95. PubMed ID: 19417773
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Costorage of Enteroendocrine Hormones Evaluated at the Cell and Subcellular Levels in Male Mice.
    Fothergill LJ; Callaghan B; Hunne B; Bravo DM; Furness JB
    Endocrinology; 2017 Jul; 158(7):2113-2123. PubMed ID: 28430903
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Down-Regulation of Renal Gluconeogenesis in Type II Diabetic Rats Following Roux-en-Y Gastric Bypass Surgery: A Potential Mechanism in Hypoglycemic Effect.
    Wen Y; Lin N; Yan HT; Luo H; Chen GY; Cui JF; Shi L; Chen T; Wang T; Tang LJ
    Obes Facts; 2015; 8(2):110-24. PubMed ID: 25832593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.